abstract |
The present invention comprises conjugates comprising a glucagon-like peptide 1 (GLP-1) fusion peptide coupled to a cyclic PYY peptide. The invention also relates to pharmaceutical compositions and methods of using them. The novel conjugates are useful for preventing, treating or ameliorating diseases and disorders described in the present disclosure. |